AVITA Medical, Inc.
RCEL
$5.16
-$0.14-2.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.28% | -74.80% | -70.25% | -63.13% | -69.63% |
| Total Depreciation and Amortization | 106.29% | 78.16% | 57.22% | 38.07% | 29.63% |
| Total Amortization of Deferred Charges | -- | -- | -74.71% | -49.56% | -24.26% |
| Total Other Non-Cash Items | 334.70% | 453.95% | 0.86% | -39.82% | -54.72% |
| Change in Net Operating Assets | 119.06% | 28.84% | 37.60% | -282.30% | -779.78% |
| Cash from Operations | 22.93% | -28.75% | -69.11% | -119.30% | -165.00% |
| Capital Expenditure | -267.42% | -564.08% | -580.09% | -507.27% | -233.93% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31,675.38% | 1,457.36% | -125.58% | -113.05% | -99.43% |
| Cash from Investing | 1,664.00% | 2,225.02% | -140.20% | -131.35% | -109.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 56.37% | 117.62% | 71.48% | 121.60% | 93.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -92.07% | -91.31% | 2,176.97% | 3,245.04% | 3,716.26% |
| Foreign Exchange rate Adjustments | -- | -- | -103.45% | -165.52% | 10.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.25% | -304.05% | -219.14% | -886.84% | -357.28% |